SMAD4 and neoplasm: Thus, ASLNC07322 overexpression abrogates the tumor-suppressive effect of SMAD4, leading to the uncontrolled expression of VEGF-C, which in turn promotes tumor lymphangiogenesis and lymphatic metastasis [114].